Rating Change
Rosenblatt analysts reiterated a Buy rating on IMAX Corporation (NYSE:IMAX) on July 20, 2026.
Rating Change Rosenblatt analysts reiterated a Buy rating on IMAX Corporation (NYSE:IMAX) on July 20, 2026. Market Context IMAX Corporation operates in the Communication Services…

Rosenblatt analysts reiterated a Buy rating on IMAX Corporation (NYSE:IMAX) on July 20, 2026.
IMAX Corporation operates in the Communication Services sector. The stock currently trades at $39.34 with a market capitalization of $2.1B. The stock has gained 38.8% over the past 52 weeks.
Analyst coverage from Rosenblatt provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for IMAX Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 20, 2026 | Rosenblatt | Buy | N/A |
| Jul 16, 2026 | Wells Fargo | Equal-Weight | N/A |
| Jul 08, 2026 | Macquarie | Outperform | N/A |
| May 22, 2026 | Benchmark | Buy | N/A |
| May 01, 2026 | Barrington Research | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View IMAX Stock Page
A Buy rating from Rosenblatt reflects the analyst's outlook on IMAX Corporation (NYSE:IMAX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the IMAX forecast page.
Current market data
NYSE · IMAX
$51.68
Up: +$0.55 · +1.08%
Live quote updated
Keep reading